Literature DB >> 27350046

Limitations of the TheraMon® -microsensor in monitoring occlusion therapy.

Charlotte Schramm1, Annegret Abaza1, Gunnar Blumenstock2, Till E Bechtold3,4, Annekatrin Rickmann5, Karl-Ulrich Bartz-Schmidt1, Dorothea Besch1, Kai Januschowski1,5.   

Abstract

PURPOSE: A proof of principle study showed that the TheraMon® -microsensor can reliably measure wearing times of glasses and occlusion patches while having no discomfort for the bearer. The goal of this study was to identify specific temperature profiles in a larger patient group wearing the microsensor with an occlusion patch on the eye, the forehead or in the trouser pocket.
METHODS: Temperature measurements with microsensors were performed at the orbital rim of the eye, at the forehead and in a trousers pocket of 20 healthy adults. The temperature measurements were analysed comparing the three locations using a repeated-measures anova with a 0.050 two-sided significance level.
RESULTS: There was no significant temperature difference in wearing the microsensors at the orbital rim compared to forehead (p = 0.507). A significant difference could be detected if the microsensors had been in trousers pockets as compared to being positioned at orbital rim/forehead (p = 0.001). The study participants reported easy handling and comfortable wearing.
CONCLUSION: This study demonstrates for the first time that TheraMon® -microsensors are fully operational in monitoring occlusion therapy in a larger group of patients (20 adult study participants). Because of the microsensor's ease of handling further studies in a larger group of children is recommended.
© 2016 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  amblyopia; compliance; microsensor; monitoring; occlusion patch

Mesh:

Year:  2016        PMID: 27350046     DOI: 10.1111/aos.13134

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  5 in total

Review 1.  [Treatment monitoring and innovations in amblyopia treatment].

Authors:  Kai Januschowski; Caroline Emmerich; Annegret Abaza; Henrike Julich-Haertel; Annekatrin Rickmann
Journal:  Ophthalmologe       Date:  2019-12       Impact factor: 1.059

2.  Monitoring of wearing and occlusion times with smart shutter glasses-A proof of concept.

Authors:  Frank R Ihmig; Kai Januschowski; Timo Koch; Thomas Velten; Annekatrin Rickmann
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

3.  Improved monitoring of adherence with patching treatment using a microsensor and Eye Patch Assistant.

Authors:  Jingyun Wang; Hongxin Xu; Bryan De La Cruz; Sarah E Morale; Reed M Jost; David A Leske; Jonathan M Holmes; Eileen E Birch
Journal:  J AAPOS       Date:  2020-03-18       Impact factor: 1.220

Review 4.  Recent Advances in Screening and Treatment for Amblyopia.

Authors:  Eileen E Birch; Krista R Kelly; Jingyun Wang
Journal:  Ophthalmol Ther       Date:  2021-09-09

5.  Electronically monitored occlusion therapy in amblyopia with eccentric fixation.

Authors:  Berna Mehmed; Maria Fronius; Tabea Pohl; Hanns Ackermann; Charlotte Schramm; Bettina Spieth; Christian Hofmann; Thomas Kohnen; Yaroslava Wenner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-10-16       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.